Cost-Effectiveness of Ponatinib in The Treatment of Patients With Chronic Phase- Chronic Myeloid Leukemia in Greece
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.212
https://www.valueinhealthjournal.com/article/S1098-3015(17)30546-6/fulltext
Title :
Cost-Effectiveness of Ponatinib in The Treatment of Patients With Chronic Phase- Chronic Myeloid Leukemia in Greece
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30546-6&doi=10.1016/j.jval.2017.08.212
First page :
A435
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
195